What Is 5-HTP

5-HTP (5-hydroxytryptophan) is an amino acid that the body naturally produces from dietary tryptophan and then converts into serotonin, a neurotransmitter central to mood regulation, sleep, and appetite. As a supplement, it is extracted from the seeds of Griffonia simplicifolia and taken orally to increase serotonin availability. It occupies a unique position in the tryptophan-to-serotonin pathway because it sits one enzymatic step away from serotonin itself, bypassing the rate-limiting conversion of tryptophan.

Serotonin influences a remarkably wide range of physiological processes: emotional tone, pain modulation, gastrointestinal motility, sleep-wake cycling, and thermoregulation. Because serotonin cannot cross the blood-brain barrier, the brain must synthesize its own supply from precursors that can. 5-HTP crosses this barrier efficiently, making it the most direct oral route to raising central serotonin levels without a prescription.

From a longevity perspective, serotonin's downstream conversion to melatonin ties 5-HTP to circadian health, a domain with growing connections to cellular repair, immune function, and metabolic regulation. Chronic low serotonin states are also associated with poor sleep quality, increased systemic inflammation, and dysregulated appetite signaling, all of which accelerate biological aging when left unaddressed. Understanding 5-HTP means understanding one lever in the broader neurochemical architecture that shapes how well the body recovers, adapts, and maintains homeostasis over decades.

The conversion pathway is straightforward. Dietary L-tryptophan enters the body and is hydroxylated by the enzyme tryptophan hydroxylase into 5-HTP. This is normally the rate-limiting step in serotonin synthesis. When 5-HTP is taken as a supplement, it skips this bottleneck entirely and proceeds directly to the next step: decarboxylation by aromatic L-amino acid decarboxylase (AADC) into serotonin (5-HT). This conversion can occur both centrally (in the brain) and peripherally (in the gut and other tissues).

Once synthesized, serotonin acts on a family of at least 14 receptor subtypes distributed throughout the brain, gut, cardiovascular system, and platelets. In the central nervous system, serotonin modulates mood, anxiety, cognition, and the perception of pain. In the pineal gland, serotonin is acetylated and methylated to form melatonin, the hormone that entrains circadian rhythm and facilitates sleep onset. This dual role means that 5-HTP supplementation can influence both daytime emotional regulation and nighttime sleep quality through a single biochemical pathway.

An important nuance is that AADC is present throughout the body, not just in the brain. Without a peripheral decarboxylase inhibitor (such as carbidopa, which is used in clinical settings but not in over-the-counter supplements), a significant portion of orally ingested 5-HTP may be converted to serotonin in the gut and bloodstream before reaching the brain. This peripheral conversion accounts for the gastrointestinal side effects some users experience and raises theoretical questions about long-term peripheral serotonin elevation affecting cardiac valves and pulmonary vasculature, though these concerns have not been substantiated at typical supplemental doses.

5-HTP is available as capsules, tablets, chewable tablets, and occasionally as a powder. Capsules are the most common form, typically containing 50 mg or 100 mg per unit. Some formulations combine 5-HTP with vitamin B6 (pyridoxal-5-phosphate), which serves as a cofactor for AADC, the enzyme that converts 5-HTP to serotonin. The rationale is that adequate B6 status supports efficient conversion, though whether co-supplementation meaningfully enhances efficacy in B6-replete individuals is unclear.

Enteric-coated or delayed-release capsules are sometimes marketed to reduce GI side effects by shifting more of the conversion from the stomach and upper intestine toward the lower gut or systemic circulation. Sublingual forms exist but are uncommon and lack comparative bioavailability data. Topical and transdermal 5-HTP products have appeared on the market, but absorption through the skin has not been demonstrated to produce meaningful increases in central serotonin. For most users, a standard immediate-release capsule taken orally remains the best-studied and most predictable delivery method.

Typical supplemental doses range from 50 mg to 300 mg per day, with most practitioners recommending a starting dose of 50 mg once daily. For mood support, doses of 150 to 300 mg per day, divided into two or three doses, have been used in clinical studies. For sleep, a single dose of 100 to 200 mg taken 30 to 60 minutes before bed is the most common protocol. For appetite regulation, doses of 250 to 300 mg taken before meals have been studied, though GI tolerance at these levels varies.

Timing matters because of the short half-life (approximately two to seven hours depending on individual metabolism). Bedtime dosing aligns serotonin elevation with the natural melatonin synthesis window. Daytime dosing for mood tends to work better when split across two to three administrations rather than taken as a single bolus. Taking 5-HTP with a small carbohydrate-containing snack may improve central uptake by triggering insulin release, which clears competing large neutral amino acids from the bloodstream and facilitates 5-HTP transport across the blood-brain barrier.

Because 5-HTP is extracted from Griffonia simplicifolia seeds, quality depends heavily on extraction and purification processes. A key concern from the late 1990s was the potential presence of Peak X, a contaminant initially identified in certain L-tryptophan supplements linked to eosinophilia-myalgia syndrome. Trace amounts of Peak X have been detected in some 5-HTP products, though at levels far below those associated with harm. Independent third-party testing (through organizations such as NSF International, USP, or ConsumerLab) provides the most reliable assurance of purity and the absence of contaminants.

Look for products that specify the Griffonia simplicifolia seed extract and state the percentage of 5-HTP content (typically standardized to 98% or greater). Avoid products that include unnecessary fillers, artificial colors, or proprietary blends where the actual 5-HTP dose is obscured. A Certificate of Analysis (COA) from an independent lab, available on request or posted on the manufacturer's website, is a reasonable minimum standard for any 5-HTP product.

The clinical evidence for 5-HTP is moderate in volume but limited in rigor. Several small randomized controlled trials, mostly conducted in the 1970s through 1990s, found that 5-HTP improved symptoms of depression compared to placebo, with some head-to-head comparisons against early antidepressants showing comparable efficacy. A Cochrane-style review of these trials noted that most suffered from small sample sizes, short durations, and methodological weaknesses that prevent firm conclusions. More recent studies have examined 5-HTP for insomnia, fibromyalgia-related pain, and appetite suppression in overweight subjects, with generally favorable but preliminary results.

Animal research has more thoroughly characterized the pharmacokinetics and neurochemical effects, confirming dose-dependent increases in brain serotonin and melatonin following 5-HTP administration. The theoretical concern about cardiac valvulopathy (extrapolated from the fenfluramine experience, which massively elevated peripheral serotonin) has not been validated in human studies at supplemental doses, but long-term safety data beyond a few months of use are essentially absent. Large-scale, well-powered trials with modern methodology are lacking, and much of the current clinical use is guided by mechanistic reasoning and practitioner experience rather than by definitive evidence.

The most common side effects are gastrointestinal: nausea, cramping, and diarrhea, which are dose-dependent and often manageable by starting low or taking 5-HTP with food. The most serious risk is serotonin syndrome when combined with serotonergic medications, including SSRIs, SNRIs, MAOIs, triptans, tramadol, and certain supplements like St. John's Wort. Prolonged high-dose use without medical oversight raises theoretical concerns about peripheral serotonin effects on cardiac valves and pulmonary vasculature, though this remains unconfirmed at standard supplemental doses. Individuals with carcinoid tumors or other serotonin-secreting conditions should avoid 5-HTP entirely. Pregnant or nursing individuals lack sufficient safety data to support use.